BBC News

People coming off weight-loss injections risk fast weight gain

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

SpringerLink

Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain

News Medical

Stopping weight loss drugs leads to rapid weight regain and health reversal

Bmj.R2586

University of Oxford

New study finds that stopping weight-loss drugs is linked to faster regain than ending diet programmes

Off-label GLP-1 use highlights the cultural pressures driving body anxieties

Independent

Why losing three stone made me more miserable than I was before

Guardian

Thursday briefing: Why skinny jabs short-term fix comes with long-term concerns

Pubmed

Even with diet and exercise, Ozempic use reduces perceived effort and praiseworthiness of resulting weight loss

The Telegraph

Slim Jab Users Gain Weight Four Times Faster Other Dieters

The Times

Weight-loss jab users pile pounds on much faster when they stop

Forbes

World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know

JAMA Network

2841273

Bmj 2025 085304

British Heart Foundation

What happens when you stop taking Mounjaro?

The Sun

Scientists finally discover how long it takes before the weight starts piling back on after stopping fat jabs

People regained weight, worsened heart health after stopping weight loss drugs: review

Daily Mail

Take fat jabs for life, experts rule - as pivotal study reveals users coming off the drugs pile the pounds back on in under two years

Healthcare Management

Patients on weight-loss injections 'regain weight faster' than other dieters

EuroNews

People regain weight within two years of coming off obesity drugs, new study finds

Daily Record

People who stop weight loss jags regain weight four times faster than dieters

RTE.ie

People who stop slimming jabs regain weight within 2 yrs

People on fat loss jabs ‘put weight back on faster than traditional dieters’

People

People Who Stop Taking Weight-Loss Medications Regain Weight Within 2 Years, Study Says

Hellorayo

Weight Loss Jabs Rapid Regain Study

Youtube

- YouTube

Research published in the British Medical Journal on Wednesday analyzed 37 studies involving more than 9,000 participants and found that people using weight management medications — including weight‑loss injections — regained an average of 0.4 kg (0.9 lb) per month after stopping treatment, returning to their pre-treatment weight within approximately 1.7 years.

Research published in the British Medical Journal on Wednesday analyzed 37 studies involving more than 9,000 participants and found that people using weight management medications — including weight‑loss injections — regained an average of 0.4 kg (0.9 lb) per month after stopping treatment, returning to their pre-treatment weight within approximately 1.7 years.

The Oxford University study found that weight regain occurred almost four times faster for people who stopped weight loss medications than for those leaving behavioral weight management programs, where regain averaged about 0.1 kg per month.

The Oxford University study found that weight regain occurred almost four times faster for people who stopped weight loss medications than for those leaving behavioral weight management programs, where regain averaged about 0.1 kg per month.

The review included GLP‑1 receptor agonist medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), though only eight of the 37 studies assessed these newer drugs, and follow-up was limited to one year after treatment stopped.

The review included GLP‑1 receptor agonist medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), though only eight of the 37 studies assessed these newer drugs, and follow-up was limited to one year after treatment stopped.

Cardiometabolic markers, including blood sugar, cholesterol, and blood pressure, improved during medication use but were projected to return to baseline within roughly 1.4 years after stopping, following the same pattern as weight regain.

Cardiometabolic markers, including blood sugar, cholesterol, and blood pressure, improved during medication use but were projected to return to baseline within roughly 1.4 years after stopping, following the same pattern as weight regain.

Across the studies, participants were treated for an average of 39 weeks and followed for an average of 32 weeks after stopping medication.

Across the studies, participants were treated for an average of 39 weeks and followed for an average of 32 weeks after stopping medication.

According to University College London research funded by Cancer Research UK, an estimated 1.6 million adults in the U.K. used weight loss drugs between early 2024 and early 2025. An additional 3.3 million people expressed interest in using these medications over the next year.

According to University College London research funded by Cancer Research UK, an estimated 1.6 million adults in the U.K. used weight loss drugs between early 2024 and early 2025. An additional 3.3 million people expressed interest in using these medications over the next year.

BBC News #

WHO #

SpringerLink #

News Medical #

BMJ #

University of Oxford #

Independent #9361

Guardian #

Pubmed #

The Telegraph #

The Times #

Forbes #3805

JAMA Network #

British Heart Foundation #

The Sun #

CBC #

Daily Mail #5681

Healthcare Management #

EuroNews #

Daily Record #

RTE.ie #

Independent #5172

People #

Hellorayo #

Youtube #

Weight loss jabs offer nothing but false hope since users regain every pound within a year or so after stopping, returning to square one faster than traditional dieters who make real lifestyle changes. The two-year prescription limit exposes the fundamental flaw: these injections create dependency without addressing underlying behaviors, leaving patients worse off when the drugs inevitably end. Throwing expensive medications at obesity while ignoring the need for genuine behavior modification and psychological support sets people up for failure and wastes resources.

Weight loss jabs offer nothing but false hope since users regain every pound within a year or so after stopping, returning to square one faster than traditional dieters who make real lifestyle changes. The two-year prescription limit exposes the fundamental flaw: these injections create dependency without addressing underlying behaviors, leaving patients worse off when the drugs inevitably end. Throwing expensive medications at obesity while ignoring the need for genuine behavior modification and psychological support sets people up for failure and wastes resources.

GLP-1 therapies represent a landmark breakthrough in treating obesity as the chronic disease it truly is, offering millions a chance to overcome a condition that kills 3.7 million people annually and costs the global economy $3 trillion by 2030. These medications deliver up to 20% weight loss and slash heart attack, stroke and death risks by 20% after three years, providing the first genuinely effective treatment option for a billion people suffering worldwide. The WHO's addition of these drugs to essential medicine lists confirms their critical role in comprehensive care that combines medication with nutrition and exercise support.

GLP-1 therapies represent a landmark breakthrough in treating obesity as the chronic disease it truly is, offering millions a chance to overcome a condition that kills 3.7 million people annually and costs the global economy $3 trillion by 2030. These medications deliver up to 20% weight loss and slash heart attack, stroke and death risks by 20% after three years, providing the first genuinely effective treatment option for a billion people suffering worldwide. The WHO's addition of these drugs to essential medicine lists confirms their critical role in comprehensive care that combines medication with nutrition and exercise support.

It's the change on the inside that matters...

It's the change on the inside that matters...

Weight Loss Drug Users Regain Weight Within 2 Years: Study

Health

Science & technology

Weight‑loss injections like Ozempic and Wegovy can produce quick results, but most users regain nearly all lost weight within a year, often faster than people following diet and exercise programs. The drugs create dependence without building lasting habits, and prolonged use can carry health risks, making lifelong reliance unrealistic and unsafe. Relying on expensive, short-term interventions while ignoring behavioral change sets millions up for failure and wastes resources on a fleeting fix.

Weight‑loss injections like Ozempic and Wegovy can produce quick results, but most users regain nearly all lost weight within a year, often faster than people following diet and exercise programs. The drugs create dependence without building lasting habits, and prolonged use can carry health risks, making lifelong reliance unrealistic and unsafe. Relying on expensive, short-term interventions while ignoring behavioral change sets millions up for failure and wastes resources on a fleeting fix.

GLP‑1 drugs like Ozempic and Wegovy can be a powerful tool for adults with obesity when combined with diet, exercise and professional support. They can produce up to 20% weight loss and reduce risks of heart attack, stroke and diabetes by around 20% over three years. Although sometimes seen as a “quick fix,” these therapies offer millions a medically validated option to supplement lifestyle changes in managing a chronic condition that causes 3.7 million deaths globally each year.

GLP‑1 drugs like Ozempic and Wegovy can be a powerful tool for adults with obesity when combined with diet, exercise and professional support. They can produce up to 20% weight loss and reduce risks of heart attack, stroke and diabetes by around 20% over three years. Although sometimes seen as a “quick fix,” these therapies offer millions a medically validated option to supplement lifestyle changes in managing a chronic condition that causes 3.7 million deaths globally each year.

Eric Thayer/Bloomberg/Getty Images

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Eric Thayer/Bloomberg/Getty Images

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Study: Weight -Loss DrugInjections UsersLinked Regainto Rapid Weight Within 2 Years: StudyRegain

The Spin

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Study: Weight -Loss DrugInjections UsersLinked Regainto Rapid Weight Within 2 Years: StudyRegain

The Spin

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters